2 Psychedelic Stocks That Will Skyrocket, According To Wall Street
Psychedelics—psychotropic drugs that trigger altered states of consciousness—are gaining widespread attention. Over the past two decades, research in the area has increased, with a magic mushroom ingredient—psilocybin—showing promise for treating a range of mental health disorders and addictions. In addition, a CB Insights market research report has shown that psychedelic medicine funding was set to cross $700 million in 2021, which is…